Outlining the implications of this c-suite trend for pharma.
Michael Abrams, MA
Advertisement
Articles by Michael Abrams, MA
Commercial-model shift demanding greater influence of these teams.
Advertisement
Latest Updated Articles
Time for Pharma to Reimagine the Medical Affairs RolePublished: June 9th 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Targeting CCR5 Receptors
2
Merck to Acquire Cidara for $9.2 Billion
3
Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML
4
Invictus Pharmacy Becomes First US Pharmacy to Accept Cryptocurrency for Prescriptions
5
